Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immune-related Adverse Event × Other hematologic neoplasm × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 188 Precursor Cell Lymphoblastic Leukemia-Lymphoma 90 Hematologic Neoplasms 80 Leukemia, Lymphocytic, Chronic, B-Cell 79 Myelodysplastic Syndromes 69 Leukemia 50 Lymphoma 42 Lymphoma, Non-Hodgkin 30 Leukemia, Myelomonocytic, Chronic 30 Burkitt Lymphoma 26 Multiple Myeloma 22 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 21 Leukemia, Biphenotypic, Acute 21 Myeloproliferative Disorders 20 Lymphoma, Large B-Cell, Diffuse 20 Recurrence 19 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 18 Neoplasms 18 Lymphoma, Mantle-Cell 18 Lymphoma, B-Cell, Marginal Zone 18 Lymphoma, Follicular 17 Hodgkin Disease 15 Waldenstrom Macroglobulinemia 13 Lymphoma, B-Cell 12 Anemia, Refractory, with Excess of Blasts 11 Myelodysplastic-Myeloproliferative Diseases 10 Leukemia, B-Cell 10 Hematologic Diseases 9 Primary Myelofibrosis 8 Melanoma 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡